Report cover image

Global Oxytocin Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 191 Pages
SKU # APRC20553026

Description

Summary

According to APO Research, The global Oxytocin market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Oxytocin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Oxytocin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Oxytocin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Oxytocin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Oxytocin include Tianjin Biochem Pharmaceutical, Shanghai Harvest Pharmaceutical, Novartis, Nanjing Xinbai Pharmaceutical, Mylan, Pfizer, GSK, Chengdu Hepatunn and Anhui Hongye Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Oxytocin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Oxytocin, also provides the sales of main regions and countries. Of the upcoming market potential for Oxytocin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oxytocin sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Oxytocin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Oxytocin sales, projected growth trends, production technology, application and end-user industry.

Oxytocin Segment by Company

Tianjin Biochem Pharmaceutical
Shanghai Harvest Pharmaceutical
Novartis
Nanjing Xinbai Pharmaceutical
Mylan
Pfizer
GSK
Chengdu Hepatunn
Anhui Hongye Pharmaceutical
Suzhou Tianji Bio-Pharmaceutical
SPH NO.1 Biochemical & Pharmaceutical
Shanghai Ceneral Pharmaceutical
Ningbo Renjian Pharmaceutical Group
Hybio Pharmaceutical
Grindeks
Oxytocin Segment by Type

Injection
Nasal Spray
Oxytocin Segment by Application

For Baby Born
For Comestic
Others
Oxytocin Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxytocin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oxytocin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxytocin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oxytocin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oxytocin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oxytocin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Oxytocin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

191 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Oxytocin Market Size, 2020 VS 2024 VS 2031
1.3 Global Oxytocin Market Size Estimates and Forecasts (2020-2031)
1.4 Global Oxytocin Sales Estimates and Forecasts (2020-2031)
1.5 Global Oxytocin Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Oxytocin Market Dynamics
2.1 Oxytocin Industry Trends
2.2 Oxytocin Industry Drivers
2.3 Oxytocin Industry Opportunities and Challenges
2.4 Oxytocin Industry Restraints
3 Oxytocin Market by Manufacturers
3.1 Global Oxytocin Revenue by Manufacturers (2020-2025)
3.2 Global Oxytocin Sales by Manufacturers (2020-2025)
3.3 Global Oxytocin Average Sales Price by Manufacturers (2020-2025)
3.4 Global Oxytocin Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Oxytocin Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Oxytocin Manufacturers, Product Type & Application
3.7 Global Oxytocin Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Oxytocin Market CR5 and HHI
3.8.2 Global Top 5 and 10 Oxytocin Players Market Share by Revenue in 2024
3.8.3 2024 Oxytocin Tier 1, Tier 2, and Tier 3
4 Oxytocin Market by Type
4.1 Oxytocin Type Introduction
4.1.1 Injection
4.1.2 Nasal Spray
4.2 Global Oxytocin Sales by Type
4.2.1 Global Oxytocin Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Oxytocin Sales by Type (2020-2031)
4.2.3 Global Oxytocin Sales Market Share by Type (2020-2031)
4.3 Global Oxytocin Revenue by Type
4.3.1 Global Oxytocin Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Oxytocin Revenue by Type (2020-2031)
4.3.3 Global Oxytocin Revenue Market Share by Type (2020-2031)
5 Oxytocin Market by Application
5.1 Oxytocin Application Introduction
5.1.1 For Baby Born
5.1.2 For Comestic
5.1.3 Others
5.2 Global Oxytocin Sales by Application
5.2.1 Global Oxytocin Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Oxytocin Sales by Application (2020-2031)
5.2.3 Global Oxytocin Sales Market Share by Application (2020-2031)
5.3 Global Oxytocin Revenue by Application
5.3.1 Global Oxytocin Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Oxytocin Revenue by Application (2020-2031)
5.3.3 Global Oxytocin Revenue Market Share by Application (2020-2031)
6 Global Oxytocin Sales by Region
6.1 Global Oxytocin Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Oxytocin Sales by Region (2020-2031)
6.2.1 Global Oxytocin Sales by Region (2020-2025)
6.2.2 Global Oxytocin Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Oxytocin Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Oxytocin Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Oxytocin Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Oxytocin Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Oxytocin Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Oxytocin Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Oxytocin Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Oxytocin Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Oxytocin Revenue by Region
7.1 Global Oxytocin Revenue by Region
7.1.1 Global Oxytocin Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Oxytocin Revenue by Region (2020-2025)
7.1.3 Global Oxytocin Revenue by Region (2026-2031)
7.1.4 Global Oxytocin Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Oxytocin Revenue (2020-2031)
7.2.2 North America Oxytocin Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Oxytocin Revenue (2020-2031)
7.3.2 Europe Oxytocin Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Oxytocin Revenue (2020-2031)
7.4.2 Asia-Pacific Oxytocin Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Oxytocin Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Oxytocin Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Tianjin Biochem Pharmaceutical
8.1.1 Tianjin Biochem Pharmaceutical Comapny Information
8.1.2 Tianjin Biochem Pharmaceutical Business Overview
8.1.3 Tianjin Biochem Pharmaceutical Oxytocin Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Tianjin Biochem Pharmaceutical Oxytocin Product Portfolio
8.1.5 Tianjin Biochem Pharmaceutical Recent Developments
8.2 Shanghai Harvest Pharmaceutical
8.2.1 Shanghai Harvest Pharmaceutical Comapny Information
8.2.2 Shanghai Harvest Pharmaceutical Business Overview
8.2.3 Shanghai Harvest Pharmaceutical Oxytocin Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Shanghai Harvest Pharmaceutical Oxytocin Product Portfolio
8.2.5 Shanghai Harvest Pharmaceutical Recent Developments
8.3 Novartis
8.3.1 Novartis Comapny Information
8.3.2 Novartis Business Overview
8.3.3 Novartis Oxytocin Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Novartis Oxytocin Product Portfolio
8.3.5 Novartis Recent Developments
8.4 Nanjing Xinbai Pharmaceutical
8.4.1 Nanjing Xinbai Pharmaceutical Comapny Information
8.4.2 Nanjing Xinbai Pharmaceutical Business Overview
8.4.3 Nanjing Xinbai Pharmaceutical Oxytocin Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Nanjing Xinbai Pharmaceutical Oxytocin Product Portfolio
8.4.5 Nanjing Xinbai Pharmaceutical Recent Developments
8.5 Mylan
8.5.1 Mylan Comapny Information
8.5.2 Mylan Business Overview
8.5.3 Mylan Oxytocin Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Mylan Oxytocin Product Portfolio
8.5.5 Mylan Recent Developments
8.6 Pfizer
8.6.1 Pfizer Comapny Information
8.6.2 Pfizer Business Overview
8.6.3 Pfizer Oxytocin Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Pfizer Oxytocin Product Portfolio
8.6.5 Pfizer Recent Developments
8.7 GSK
8.7.1 GSK Comapny Information
8.7.2 GSK Business Overview
8.7.3 GSK Oxytocin Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 GSK Oxytocin Product Portfolio
8.7.5 GSK Recent Developments
8.8 Chengdu Hepatunn
8.8.1 Chengdu Hepatunn Comapny Information
8.8.2 Chengdu Hepatunn Business Overview
8.8.3 Chengdu Hepatunn Oxytocin Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Chengdu Hepatunn Oxytocin Product Portfolio
8.8.5 Chengdu Hepatunn Recent Developments
8.9 Anhui Hongye Pharmaceutical
8.9.1 Anhui Hongye Pharmaceutical Comapny Information
8.9.2 Anhui Hongye Pharmaceutical Business Overview
8.9.3 Anhui Hongye Pharmaceutical Oxytocin Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Anhui Hongye Pharmaceutical Oxytocin Product Portfolio
8.9.5 Anhui Hongye Pharmaceutical Recent Developments
8.10 Suzhou Tianji Bio-Pharmaceutical
8.10.1 Suzhou Tianji Bio-Pharmaceutical Comapny Information
8.10.2 Suzhou Tianji Bio-Pharmaceutical Business Overview
8.10.3 Suzhou Tianji Bio-Pharmaceutical Oxytocin Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Suzhou Tianji Bio-Pharmaceutical Oxytocin Product Portfolio
8.10.5 Suzhou Tianji Bio-Pharmaceutical Recent Developments
8.11 SPH NO.1 Biochemical & Pharmaceutical
8.11.1 SPH NO.1 Biochemical & Pharmaceutical Comapny Information
8.11.2 SPH NO.1 Biochemical & Pharmaceutical Business Overview
8.11.3 SPH NO.1 Biochemical & Pharmaceutical Oxytocin Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 SPH NO.1 Biochemical & Pharmaceutical Oxytocin Product Portfolio
8.11.5 SPH NO.1 Biochemical & Pharmaceutical Recent Developments
8.12 Shanghai Ceneral Pharmaceutical
8.12.1 Shanghai Ceneral Pharmaceutical Comapny Information
8.12.2 Shanghai Ceneral Pharmaceutical Business Overview
8.12.3 Shanghai Ceneral Pharmaceutical Oxytocin Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Shanghai Ceneral Pharmaceutical Oxytocin Product Portfolio
8.12.5 Shanghai Ceneral Pharmaceutical Recent Developments
8.13 Ningbo Renjian Pharmaceutical Group
8.13.1 Ningbo Renjian Pharmaceutical Group Comapny Information
8.13.2 Ningbo Renjian Pharmaceutical Group Business Overview
8.13.3 Ningbo Renjian Pharmaceutical Group Oxytocin Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Ningbo Renjian Pharmaceutical Group Oxytocin Product Portfolio
8.13.5 Ningbo Renjian Pharmaceutical Group Recent Developments
8.14 Hybio Pharmaceutical
8.14.1 Hybio Pharmaceutical Comapny Information
8.14.2 Hybio Pharmaceutical Business Overview
8.14.3 Hybio Pharmaceutical Oxytocin Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 Hybio Pharmaceutical Oxytocin Product Portfolio
8.14.5 Hybio Pharmaceutical Recent Developments
8.15 Grindeks
8.15.1 Grindeks Comapny Information
8.15.2 Grindeks Business Overview
8.15.3 Grindeks Oxytocin Sales, Price, Revenue and Gross Margin (2020-2025)
8.15.4 Grindeks Oxytocin Product Portfolio
8.15.5 Grindeks Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Oxytocin Value Chain Analysis
9.1.1 Oxytocin Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Oxytocin Production Mode & Process
9.2 Oxytocin Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Oxytocin Distributors
9.2.3 Oxytocin Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.